Quarterly Financial Information (Unaudited)

12 Months Ended

Dec. 31, 2019

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information (Unaudited)

21. Quarterly Financial Information (Unaudited)

(in millions, except per share data)
	2019 Quarter Ended								2018 Quarter Ended
	Mar		Jun		Sep		Dec		Mar		Jun		Sep		Dec
Net sales	$	1,975.5	$	1,988.6	$	1,892.4	$	2,125.7	$	2,017.6	$	2,007.6	$	1,836.7	$	2,071.0
Gross profit		1,278.7		1,260.4		1,210.1		1,396.1		1,291.0		1,274.4		1,160.1		1,339.6
Net earnings (loss) of Zimmer    Biomet Holdings, Inc.		246.1		133.7		431.1		320.7		174.7		185.0		162.2		(901.1	)
Earnings (loss) per common    share
Basic		1.20		0.65		2.10		1.56		0.86		0.91		0.80		(4.42	)
Diluted		1.20		0.65		2.08		1.54		0.85		0.90		0.79		(4.42	)

In the three month period ended December 31, 2019, we recognized a $51.2 million tax benefit related to TRAF as well as the tax impact of certain restructuring transactions in Switzerland.

In the three month period ended December 31, 2018, we recorded goodwill impairment charges of $975.9 million.